Episode image

J-Alex Trial: Should Alecensa Replace Xalkori as First-Line ALK Therapy?


Episode   ·  0 Play

Episode  ·  11:02  ·  Aug 4, 2016


GRACE is happy to present the 5th in our series ASCO 2016 Lung Cancer Roundtable, Highlights and New Approaches in Lung Cancer.  Featuring Jack West, MD, Janet Freeman-Daily, Everett Vokes, MD, and Suresh Ramalingam, MD, this roundtable discussion, moderated by Dr. West, highlights the newest and most intriguing discussions from ASCO 2016. Drs. West, Vokes and Ramalingam, along with patient advocate Janet Freeman-Daily, discuss the J-Alex trial and whether Alecensa should replace Xalkori as First-Line ALK Therapy.

11m 2s  ·  Aug 4, 2016

© 2016 Spreaker (OG)